Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer
Sensible Medicine
JULY 30, 2024
In this context, the Canary Prostate Active Surveillance Study ( PASS ) sought to understand the long-term outcomes of active surveillance. Question What are the long-term outcomes for patients with favorable risk prostate cancer managed with protocol-directed active surveillance? The cohort enrolled patients from 2008 to 2022.
Let's personalize your content